Table of Contents
Journal of Allergy
Volume 2012, Article ID 694094, 5 pages
http://dx.doi.org/10.1155/2012/694094
Clinical Study

Can Serum-Specific IgE/Total IgE Ratio Predict Clinical Response to Allergen-Specific Immunotherapy in Children Monosensitized to House Dust Mite?

Division of Pediatric Allergy and Immunology, Faculty of Medicine, University of Cukurova, Balcali, 01330 Adana, Turkey

Received 18 November 2011; Revised 24 January 2012; Accepted 24 January 2012

Academic Editor: Nazan Cobanoglu

Copyright © 2012 Gulbin Bingol Karakoc et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U. Wahn, “Immunotherapy in children,” Current Opinion in Allergy and Clinical Immunology, vol. 2, no. 6, pp. 557–560, 2002. View at Publisher · View at Google Scholar
  2. M. J. Abramson, R. M. Puy, and J. M. Weiner, “Allergen immunotherapy for asthma,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD001186, 2003. View at Google Scholar · View at Scopus
  3. W. Gruber, E. Eber, P. Mileder, M. Modl, E. Weinhandl, and M. S. Zach, “Effect of specific immunotherapy with house dust mite extract on the bronchial responsiveness of paediatric asthma patients,” Clinical and Experimental Allergy, vol. 29, no. 2, pp. 176–181, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. H. P. Van Bever and W. J. Stevens, “Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus),” Clinical and Experimental Allergy, vol. 19, no. 4, pp. 399–404, 1989. View at Publisher · View at Google Scholar · View at Scopus
  5. N. F. Adkinson, P. A. Eggleston, D. Eney et al., “A controlled trial of immunotherapy for asthma in allergic children,” The New England Journal of Medicine, vol. 336, no. 5, pp. 324–331, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Akdis and C. A. Akdis, “Mechanisms of allergen-specific immunotherapy,” Journal of Allergy and Clinical Immunology, vol. 119, no. 4, pp. 780–789, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. C. A. Akdis and K. Blaser, “IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy,” FASEB Journal, vol. 13, no. 6, pp. 603–609, 1999. View at Google Scholar · View at Scopus
  8. S. R. Durham and S. J. Till, “Immunologic changes associated with allergen immunotherapy,” Journal of Allergy and Clinical Immunology, vol. 102, no. 2, pp. 157–164, 1998. View at Google Scholar · View at Scopus
  9. S. J. Till, J. N. Francis, K. Nouri-Aria, and S. R. Durham, “Mechanisms of immunotherapy,” Journal of Allergy and Clinical Immunology, vol. 113, no. 6, pp. 1025–1034, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Jutel, M. Akdis, F. Budak et al., “IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy,” European Journal of Immunology, vol. 33, no. 5, pp. 1205–1214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. C. A. Akdis, T. Blesken, M. Akdis, B. Wüthrich, and K. Blaser, “Role of interleukin 10 in specific immunotherapy,” Journal of Clinical Investigation, vol. 102, no. 1, pp. 98–106, 1998. View at Google Scholar · View at Scopus
  12. C. A. Akdis, A. Joss, M. Akdis, A. Faith, and K. Blaser, “A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding,” FASEB Journal, vol. 14, no. 12, pp. 1666–1668, 2000. View at Google Scholar · View at Scopus
  13. R. Van Ree, W. A. Van Leeuwen, P. H. Dieges et al., “Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy,” Clinical and Experimental Allergy, vol. 27, no. 1, pp. 68–74, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. G. J. Gleich, E. M. Zimmermann, L. L. Henderson, and J. W. Yunginger, “Effect of immunotherapy on immunoglobulin E and immunoglogulin G antibodies to ragweed antigens: a six-year prospective study,” Journal of Allergy and Clinical Immunology, vol. 70, no. 4, pp. 261–271, 1982. View at Google Scholar · View at Scopus
  15. C. G. Jakobsen, U. Bodtger, L. K. Poulsen, and E. L. Roggen, “Vaccination for birch pollen allergy: comparison of the affinities of specific immunoglobulins E, G1 and G4 measured by surface plasmon resonance,” Clinical and Experimental Allergy, vol. 36, no. 2, pp. 193–198, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Torres Lima, D. Wilson, L. Pitkin et al., “Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial,” Clinical and Experimental Allergy, vol. 32, no. 4, pp. 507–514, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. P. A. Wachholz and S. R. Durham, “Induction of 'blocking' IgG antibodies during immunotherapy,” Clinical and Experimental Allergy, vol. 33, no. 9, pp. 1171–1174, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Gehlhar, M. Schlaak, W. Becker, and A. Bufe, “Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome,” Clinical and Experimental Allergy, vol. 29, no. 4, pp. 497–506, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. B. E. Garcia, M. L. Sanz, J. J. Gato, J. Fernandez, and A. Oehling, “IgG4 blocking effect on the release of antigen-specific histamine,” Journal of Investigational Allergology and Clinical Immunology, vol. 3, no. 1, pp. 26–33, 1993. View at Google Scholar · View at Scopus
  20. G. Di Lorenzo, P. Mansueto, M. L. Pacor et al., “Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy,” Journal of Allergy and Clinical Immunology, vol. 123, no. 5, pp. 1103–1110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Global Initiative for Asthma (GINA), Global Strategy for Asthma Management and Prevention, 2007.
  22. J. Bousquet, N. Khaltaev, A. A. Cruz et al., “Allergic rhinitis and its impact on asthma (ARIA) 2008,” Allergy, vol. 63, supplement 86, pp. 8–160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Majak, J. Kaczmarek-Woźniak, A. Brzozowska, M. Bobrowska-Korzeniowska, J. Jerzynska, and I. Stelmach, “One-year follow-up of clinical and inflammatory parameters in children allergic to grass pollen receiving high-dose ultrarush sublingual immunotherapy,” Journal of Investigational Allergology and Clinical Immunology, vol. 20, no. 7, pp. 602–606, 2010. View at Google Scholar
  24. G. Ciprandi, I. Cirillo, A. Vizzaccaro, M. Milanese, and M. A. Tosca, “Correlation of nasal inflammation and nasal airflow with forced expiratory volume in 1 second in patients with perennial allergic rhinitis and asthma,” Annals of Allergy, Asthma and Immunology, vol. 93, no. 6, pp. 575–580, 2004. View at Google Scholar · View at Scopus
  25. C. Gudex, P. Dolan, P. Kind, and A. Williams, “Health state valuations from the general public using the visual analogue scale,” Quality of Life Research, vol. 5, no. 6, pp. 521–531, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. “Standardization of spirometry: 1994 Update,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 3, pp. 1107–1136, 1995.
  27. A. O. Eifan, M. H. Shamji, and S. R. Durham, “Long-term clinical and immunological effects of allergen immunotherapy,” Current Opinion in Allergy and Clinical Immunology, vol. 11, no. 6, pp. 586–593, 2011. View at Publisher · View at Google Scholar
  28. S. R. Durham and M. H. Shamji, “Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials,” Allergy, vol. 41, no. 9, pp. 1235–1246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. C. S. Hankin, L. Cox, and A. Bronstone, “The health economics of allergen immunotherapy,” Immunology and Allergy Clinics of North America, vol. 31, no. 2, pp. 325–341, 2011. View at Publisher · View at Google Scholar
  30. G. Senna, E. Ridolo, M. Calderon, C. Lombardi, G. W. Canonica, and G. Passalacqua, “Evidence of adherence to allergen-specific immunotherapy,” Current Opinion in Allergy and Clinical Immunology, vol. 9, no. 6, pp. 544–548, 2009. View at Publisher · View at Google Scholar · View at Scopus